Labcorp to Speak at the UBS 2022 Global Healthcare Conference May 17, 2022 at 12:01 PM EDT Download PDF 219.1 KB BURLINGTON, N.C.--(BUSINESS WIRE)--May 17, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Tuesday, May 24 at 2:45 p.m. ET. A live webcast of the fireside chat will be available via the Labcorp Investor Relations website and archived for replay. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in 2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. # # # View source version on businesswire.com: https://www.businesswire.com/news/home/20220517006005/en/ Labcorp Contacts: Investors: Chas Cook — 336-436-5076Investor@Labcorp.com Media: Christopher Allman-Bradshaw — 336-436-8263Media@Labcorp.com Source: Labcorp
